{"product_id":"global-monoclonal-antibody-therapy-market-growth-status-and-outlook-2023-2029","title":"Global Monoclonal Antibody Therapy Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Monoclonal Antibody Therapy Market Growth (Status and Outlook) 2023-2029\u003cbr\u003e\nAntibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.\u003c\/p\u003e\n\n\n\n\u003cp\u003eTreatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Monoclonal Antibody Therapy Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Therapy sales for 2023 through 2029. With Monoclonal Antibody Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Therapy industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Therapy market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Therapy.\u003c\/p\u003e\n\n\u003cp\u003eThe global Monoclonal Antibody Therapy market size is projected to grow from US$ 111700 million in 2022 to US$ 183700 million in 2029; it is expected to grow at a CAGR of 7.4% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eThe industry's leading producers are Roche, Abbvie and J \u0026amp; J, with revenues of 15.61%, 12.10% and 10.05% in 2019.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Therapy market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nHuman Monoclonal Antibody\u003cbr\u003e\nHumanized Monoclonal Antibody\u003cbr\u003e\nChimeric Monoclonal Antibody\u003cbr\u003e\nMurine Monoclonal Antibody\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nCancer\u003cbr\u003e\nAutoimmune Diseases\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nAbbvie\u003cbr\u003e\nAmgen\u003cbr\u003e\nGlaxosmithkline\u003cbr\u003e\nMerck\u003cbr\u003e\nNovartis\u003cbr\u003e\nRoche\u003cbr\u003e\nJohson \u0026amp; Johson\u003cbr\u003e\nNovartis\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 86 Pages \/ MCW16227536","offer_id":47645971349810,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true},{"title":"February, 2023 \/ 86 Pages \/ MCW16227537","offer_id":47645971382578,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-monoclonal-antibody-therapy-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}